MesotheliomaDR logo

24/7 Patient Assistance: 760-405-8205

Cheng Chee, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy

  • Bio & Insurance Information
  • Education & Training

    dept_icon

    Royal Free Hospital and University College London Medical School

    Medical School

    dept_icon

    Mayo School of Graduate Medical Education

    Residency

    dept_icon

    Mayo School of Graduate Medical Education

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Publications & Memberships

    Dr. Cheng Chee has contributed to 3 publications.

    Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.

    Chee CE Krishnamurthi S Nock CJ Meropol NJ Gibbons J Fu P Bokar J Teston L O'Brien T Gudena V Reese A Bergman M Saltzman J Wright JJ Dowlati A Brell J; Oncologist. 2013 .

    See more >>

    Targeted therapeutic agents for colorectal cancer.

    Chee, C.E., Sinicrope, F.A.; Gastroenterol Clin North Am. 2010 Sep

    See more >>

    Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.

    Larsen, J.T., Chee, C.E., Lust, J.A., Greipp, P.R., Rajkumar, S.V.; Blood. 2011 Sep 8.

    See more >>